Literature DB >> 15782113

Partial downregulation of MAD1 causes spindle checkpoint inactivation and aneuploidy, but does not confer resistance towards taxol.

Anne Kienitz1, Celia Vogel, Ivonne Morales, Rolf Müller, Holger Bastians.   

Abstract

The mitotic spindle assembly checkpoint ensures proper chromosome segregation during mitosis by inhibiting the onset of anaphase until all kinetochores are attached to the mitotic spindle and tension across the kinetochores is generated. Here, we report that the stable partial downregulation of the spindle checkpoint gene MAD1, which is observed in human cancer, leads to a functional inactivation of the spindle checkpoint resulting in gross aneuploidy. Interestingly, although Mad1 is thought to act as a kinetochore based activator of Mad2 during checkpoint activation, we show that normal levels of Mad2, but not of Mad1, are required for preventing premature sister chromatid separation and for maintaining the timing of an undisturbed mitosis, suggesting a Mad1 independent function of Mad2 that operates independent of its checkpoint function. Most significantly, a partial repression of either MAD1 or MAD2 confers resistance to nocodazole, a drug that inhibits microtubule attachment. In contrast, sensitivity to clinically relevant drugs like taxol or monastrol that inhibit the generation of tension across kinetochores is not modulated by partial downregulation of MAD1, suggesting a functional bifurcation of spindle checkpoint dependent apoptotic pathways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15782113     DOI: 10.1038/sj.onc.1208589

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  29 in total

Review 1.  Mitosis in vertebrates: the G2/M and M/A transitions and their associated checkpoints.

Authors:  Conly L Rieder
Journal:  Chromosome Res       Date:  2011-04       Impact factor: 5.239

2.  Up-regulation of the mitotic checkpoint component Mad1 causes chromosomal instability and resistance to microtubule poisons.

Authors:  Sean D Ryan; Eric M C Britigan; Lauren M Zasadil; Kristen Witte; Anjon Audhya; Avtar Roopra; Beth A Weaver
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

3.  MAD1 (mitotic arrest deficiency 1) is a candidate for a tumor suppressor gene in human stomach.

Authors:  Mitsuhiko Osaki; Toshiaki Inoue; Shigeyuki Yamaguchi; Aiko Inaba; Naruo Tokuyasu; Kuan-Teh Jeang; Mitsuo Oshimura; Hisao Ito
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

Review 4.  Spindle checkpoint function and cellular sensitivity to antimitotic drugs.

Authors:  Hiroshi Y Yamada; Gary J Gorbsky
Journal:  Mol Cancer Ther       Date:  2006-12       Impact factor: 6.261

Review 5.  Targeting mitotic pathways for endocrine-related cancer therapeutics.

Authors:  Shivangi Agarwal; Dileep Varma
Journal:  Endocr Relat Cancer       Date:  2017-06-14       Impact factor: 5.678

6.  Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells.

Authors:  Aniek Janssen; Geert J P L Kops; René H Medema
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-23       Impact factor: 11.205

7.  miR-125b promotes cell death by targeting spindle assembly checkpoint gene MAD1 and modulating mitotic progression.

Authors:  S Bhattacharjya; S Nath; J Ghose; G P Maiti; N Biswas; S Bandyopadhyay; C K Panda; N P Bhattacharyya; S Roychoudhury
Journal:  Cell Death Differ       Date:  2012-10-26       Impact factor: 15.828

Review 8.  Role of prolonged mitotic checkpoint activation in the formation and treatment of cancer.

Authors:  W Brian Dalton; Vincent W Yang
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

9.  Mitotic arrest deficient-like 1 is correlated with poor prognosis in small-cell lung cancer after surgical resection.

Authors:  Dandan Li; Qingwei Meng; Huijuan Zhang; Ting Feng; Meiyan Liu; Li Cai
Journal:  Tumour Biol       Date:  2015-10-24

10.  p53 suppresses structural chromosome instability after mitotic arrest in human cells.

Authors:  W B Dalton; B Yu; V W Yang
Journal:  Oncogene       Date:  2010-01-11       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.